国家: 美国
语言: 英文
来源: NLM (National Library of Medicine)
OXYCODONE HYDROCHLORIDE (UNII: C1ENJ2TE6C) (OXYCODONE - UNII:CD35PMG570), ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D)
Endo Pharmaceuticals Inc.
OXYCODONE HYDROCHLORIDE
OXYCODONE HYDROCHLORIDE 2.5 mg
ORAL
PRESCRIPTION DRUG
PERCOCET is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see WARNINGS ], reserve PERCOCET for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - Have not been tolerated, or are not expected to be tolerated, - Have not provided adequate analgesia, or are not expected to provide adequate analgesia PERCOCET is contraindicated in patients with: - Significant respiratory depression [see WARNINGS ] - Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see WARNINGS ] - Known or suspected gastrointestinal obstruction, including paralytic ileus [see WARNINGS ] - Hypersensitivity to oxycodone, acetaminophen, or any other component of the product (e.g., anaphylaxis) [see WARNINGS, ADVERSE REACTIONS ] PERCOCET contains oxycodone, a
PERCOCET (Oxycodone and Acetaminophen Tablets, USP) is supplied as follows: 2.5 mg/325 mg Pink, oval, tablet, debossed with “PERCOCET” on one side and “2.5” on the other. Bottles of 100 NDC 63481-627-70 5 mg/325 mg Blue, round, tablet, debossed with “PERCOCET” and “5” on one side and bisect on the other. Bottles of 100 NDC 63481-623-70 Bottles of 500 NDC 63481-623-85 7.5 mg/325 mg Peach, oval-shaped, tablet, debossed with “PERCOCET” on one side and “7.5/325” on the other. Bottles of 100 NDC 63481-628-70 10 mg/325 mg Yellow, capsule-shaped, tablet, debossed with “PERCOCET” on one side and “10/325” on the other. Bottles of 100 NDC 63481-629-70 Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture. Dispense in a tight, light-resistant container as defined in the USP. Store PERCOCET securely and dispose of properly [see PRECAUTIONS/Information for Patients ]. DEA Order Form Required. Distributed by: Endo Pharmaceuticals Inc. Malvern, PA 19355 Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 PERCOCET® is a registered trademark of Endo Pharmaceuticals Inc. © 2017 Endo Pharmaceuticals Inc. All rights reserved. Printed in U.S.A. Revised: August 2020
Abbreviated New Drug Application
Endo Pharmaceuticals Inc. ---------- Medication Guide PERCOCET® (ˈpər-kō-ˌset) Tablets, CII PERCOCET is: • A strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain, severe enough to require an opioid analgesic and for which alternative treatments are inadequate and when other pain treatments such as non-opioid pain medicines do not treat your pain well enough or you cannot tolerate them. • An opioid pain medicine that can put you at risk for overdose and death. Even if you take your dose correctly as prescribed you are at risk for opioid addiction, abuse, and misuse that can lead to death. Important information about PERCOCET tablets: • Get emergency help or call 911 right away if you take too much PERCOCET (overdose). When you first start taking PERCOCET, when your dose is changed, or if you take too much (overdose), serious or life-threatening breathing problems that can lead to death may occur. Talk to your healthcare provider about naloxone, a medicine for the emergency treatment of an opioid overdose.Taking PERCOCET with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death. • Never give anyone else your PERCOCET. They could die from taking it. Selling or giving away PERCOCET is against the law. • Store PERCOCET securely, out of sight and reach of children, and in a location not accessible by others, including visitors to the home. Do not take PERCOCET if you have: • Severe asthma, trouble breathing, or other lung problems. • A bowel blockage or have narrowing of the stomach or intestines. • Known hypersensitivity to oxycodone, acetaminophen, or any ingredient in PERCOCET. Before taking PERCOCET, tell your healthcare provider if you have a history of: • Head injury, seizures • Liver, kidney, thyroid problems • Problems urinating • Pancreas or gallbladder problems • Abuse of street or pres 阅读完整的文件
PERCOCET- OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN TABLET ENDO PHARMACEUTICALS INC. ---------- PERCOCET (OXYCODONE AND ACETAMINOPHEN TABLETS, USP) CII RX ONLY REVISED: AUGUST 2020 ® WARNING: ADDICTION, ABUSE, AND MISUSE; RISK EVALUATION AND MITIGATION STRATEGY (REMS); LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME, CYTOCHROME P450 3A4 INTERACTION; HEPATOTOXICITY, AND RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS ADDICTION, ABUSE, AND MISUSE PERCOCET EXPOSES PATIENTS AND OTHER USERS TO THE RISKS OF OPIOID ADDICTION, ABUSE, AND MISUSE, WHICH CAN LEAD TO OVERDOSE AND DEATH. ASSESS EACH PATIENT’S RISK PRIOR TO PRESCRIBING PERCOCET, AND MONITOR ALL PATIENTS REGULARLY FOR THE DEVELOPMENT OF THESE BEHAVIORS AND CONDITIONS [SEE WARNINGS]. OPIOID ANALGESIC RISK EVALUATION AND MITIGATION STRATEGY (REMS): TO ENSURE THAT THE BENEFITS OF OPIOID ANALGESICS OUTWEIGH THE RISKS OF ADDICTION, ABUSE, AND MISUSE, THE FOOD AND DRUG ADMINISTRATION (FDA) HAS REQUIRED A REMS FOR THESE PRODUCTS [SEE WARNINGS]. UNDER THE REQUIREMENTS OF THE REMS, DRUG COMPANIES WITH APPROVED OPIOID ANALGESIC PRODUCTS MUST MAKE REMS-COMPLIANT EDUCATION PROGRAMS AVAILABLE TO HEALTHCARE PROVIDERS. HEALTHCARE PROVIDERS ARE STRONGLY ENCOURAGED TO COMPLETE A REMS-COMPLIANT EDUCATION PROGRAM, COUNSEL PATIENTS AND/OR THEIR CAREGIVERS, WITH EVERY PRESCRIPTION, ON SAFE USE, SERIOUS RISKS, STORAGE, AND DISPOSAL OF THESE PRODUCTS, EMPHASIZE TO PATIENTS AND THEIR CAREGIVERS THE IMPORTANCE OF READING THE MEDICATION GUIDE EVERY TIME IT IS PROVIDED BY THEIR PHARMACIST, AND CONSIDER OTHER TOOLS TO IMPROVE PATIENT, HOUSEHOLD, AND COMMUNITY SAFETY. LIFE-THREATENING RESPIRATORY DEPRESSION SERIOUS, LIFE-THREATENING, OR FATAL RESPIRATORY DEPRESSION MAY OCCUR WITH USE OF PERCOCET. MONITOR FOR RESPIRATORY DEPRESSION, ESPECIALLY DURING INITIATION OF PERCOCET OR FOLLOWING A DOSE INCREASE [SEE WARNINGS]. ACCIDENTAL INGESTION ACCIDENTAL INGESTION OF PERCOCET, ESPECIALLY BY CHILDREN, CAN RESULT IN A FA 阅读完整的文件